gem-Diphosphonate and gem-phosphonate-phosphate compounds with specific high density lipoprotein inducing activity
- 1 August 1987
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 30 (8) , 1426-1433
- https://doi.org/10.1021/jm00391a027
Abstract
New diphosphonate compounds and related derivatives1 were synthesized and investigated for their activity in specifically inducing plasma high density lipoproteins (HDL) and high density lipoprotein cholesterol (HDL-C) in normal rats. The screening of numerous compounds has permitted the determination of the structural variations leading to optimal plasma lipid altering activity, indicating antiatherosclerotic potential. Among the compounds observed to be the most active, dimethyl .alpha.-(dimethoxyphosphinyl)-p-chlorobenzyl phosphate, (20, SR-202, mifobate) was selected for further pharmacological and subsequent clinical development.This publication has 6 references indexed in Scilit:
- Novel pyrimidine and 1,3,5-triazine hypolipemic agentsJournal of Medicinal Chemistry, 1984
- Phenylenebis(oxy)bis[2,2-dimethylpentanoic acids]: agents that elevate high-density lipoproteinsJournal of Medicinal Chemistry, 1983
- Atherosclerotic plaque regression in rhesus monkeys induced by bile acid sequestrantExperimental and Molecular Pathology, 1979
- ANIMAL-MODELS FOR AN INTEGRATED APPROACH TO THE PHARMACOLOGIC CONTROL OF ATHEROSCLEROSIS1979
- 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acidsJournal of Medicinal Chemistry, 1977
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955